Abstract
Clinical and endoscopic findings were compared with 24-hr pH profiles in 8 patients with Zollinger-Ellison syndrome (ZES), who were being treated, during consecutive periods, with doses of cimetidine or ranitidine. There was a positive correlation between the effect on gastric pH and the outcome of treatment, with ranitidine proving to be more effective. The reduction of gastric acidity was correlated with ranitidine plasma levels. In the medical management of ZES patients, the 24-hr pH profile appears to be a measurement which is of value in the choice of appropriate drug regimes and which promises to increase our understanding of treatment failure.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bonfils S, Mignon M, Gratton J: Cimetidine treatment of acute and chronic Zollinger-Ellison syndrome. World J Surg 3:597–604, 1979
McCarthy DM: Report on the United States experience with cimetidine in Zollinger-Ellison syndrome and other hypersecretory states. Gastroenterology 74:453–458, 1978
Mignon M, Vallot T, Bonfils S: Use of ranitidine in the management of Zollinger-Ellison syndrome.In Proceedings of the International Symposium on Clinical Use of Ranitidine (London October 8–10, 1981). JJ Misiewicz, KG Wormsley (eds). Oxford, Medicine Publishing Foundation, 1982, pp 281–282
Mignon M, Vallot T, Galmiche JP, Dupas JL, Bonfils S: Interest of a combined antisecretory treatment, cimetidine and pirenzepine, in the management of severe forms of Zollinger-Ellison syndrome Digestion 20:56–61, 1980
Londong W, Londong V Ruthe C, Weizert P: Complete inhibition of food stimulated gastric acid secretion by combined application of pirenzepine and ranitidine. Gut 22:542–548, 1981
Peterson WL, Barnett C, Feldman M, Richardson C: Reduction of twenty four hour gastric acidity with combination drug therapy in patients with duodenal ulcer. Gastroenterology 77:1015–1020, 1979
Walt RP Male PJ, Rawlings J, Hunt RH, Milton Thompson CJ, Misiewicz JJ: Comparison of the effects of ranitidine, cimetidine and placebo on the 24 hour intragastric acidity and nocturnal acid secretion in patients with duodenal ulcer. Gut 22:49–54, 1981
Galmiche JP, Vallot T, Mayeur S, Arsene D, Ducrotte P, Duvaldestin P Mignon M: Effet de la ranitidine sur le pH gastrique chez le sujet sain. Interêt de l'enregistrement continu sur 24 heures pour le choix du fractionnement optimal d'une dose thérapeutique. Gastroenterol Clin Biol 6:352–395, 1982
Carey PF, Martin LE: A high performance liquid chromatography method for the determination of ranitidine in plasma, J Liq Chromatogr 2:1291–1303, 1979
Bonfils S, Dubrasquet M, Lewin MJM, Mignon M: Assessment of efficacy of histamine H2-receptor antagonists on various experimental and clinical models.In Drugs and Peptic Ulcer, Vol 1. CJ Pfeiffer (ed). Boca Raton, CRC, 1981, pp 66–78
Mignon M, Vallot T, Mayeur S, Bonfils S: Ranitidine and cimetidine in Zollinger-Ellison syndrome. Br J Clin Pharmacol 10:193–194, 1980
Bonfils S, Mignon M, Jian R, Kloeti G: Biological studies during long term cimetidine administration in the Zollinger-Ellison syndrome.In Cimetidine. WL Bürland, MA Simkins (eds.) Amsterdam, Excerpta Medica, 1977, pp 311–321
Collins SM, Jensen RT, Korman LY, McCarthy KM, Gardner JD: The relation between symptoms and gastric acid secretion in medically treated patients with Zollinger-Ellison syndrome Gastroenterology 80:1127A, 1981
McCarthy DM, Hyman PE: The effect of isopropamide on the response to oral cimetidine in patients with Zollinger-Ellison syndrome. Dig Dis Sci 27:353–359, 1982
Bonfils S Mignon M, Landor JH: Management of Zollinger-Ellison syndrome. N Engl J Med 303:942, 1980
Stage JG, Bonfils S, Mignon M, StadilF: Prolonged secretory inhibition during cimetidine treatment in Zollinger-Ellison patients. Scand J Gastroenterol 17:401–404, 1982
Bonfils S: Testing antisecretory drugs in the Zollinger-Ellison syndrome: Problems and limits in pharmacological studies. Dig Dis Sci 27:377–378, 1982
Vallot T, Farinotti R, Mazure R, Mignon M, Dauphin A, Bonfils S: L'absorption intestinale de la ranitidine est-elle modifiée au cours du syndrome de Zollinger-Ellison (SZE)? Gastroenterol Clin Biol 7:51A, 1983
Dubois A Van Eerdewegh P, Gardner JD: Gastric emptying and secretion in the Zollinger-Ellison syndrome. J Clin Invest 59:255–263, 1977
Harrison A, Ippoliti A, Cullison R: Rapid gastric emptying in Zollinger-Ellison syndrome. Gastroenterology 78:1181A, 1980
Rambaud JC, Matuchansky C: Diarrhoea and digestive endocrine tumours. Clin Gastroenterol 3:657–670, 1974
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Vallot, T., Mignon, M., Mazure, R. et al. Evaluation of antisecretory drug therapy of zollinger-ellison syndrome (ZES) using 24-hour pH monitoring. Digest Dis Sci 28, 577–584 (1983). https://doi.org/10.1007/BF01299916
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01299916